What is BioMimetic Therapeutics’ ticker symbol?

On what exchange is BioMimetic traded?
BioMimetic is traded on the NASDAQ Global Market.

What is BioMimetic’s stock CUSIP number?
09064X 10 1

Who is BioMimetic’s stock transfer agent?
American Stock Transfer & Trust
59 Maiden Lane
New York, NY 10007
(800) 937-5449

May I purchase shares of stock directly from the Company?
No. BioMimetic does not have a direct stock purchase plan. Please contact your stock broker of choice to purchase shares.

Does the Company issue dividends on its common stock?
BioMimetic does not currently issue dividends.

How many shares of BioMimetic stock are outstanding?
As of March 4, 2011, BioMimetic had 27,933,329 outstanding shares of common stock.

What year was BioMimetic incorporated?
The company was officially incorporated in May 2001 in the State of Delaware under the name BioMimetic Pharmaceuticals, Inc. In August 2005, we subsequently changed our name to BioMimetic Therapeutics, Inc.

Who is the CEO of BioMimetic?
Samuel E. Lynch, D.M.D., D.M.Sc. is President and CEO.

How many employees does BioMimetic have?
As of January 1, 2010 the Company employed approximately 90 individuals.

When did BioMimetic go public?
BioMimetic went public on May 12, 2006.

Who is BioMimetic’s independent auditor?
The international accounting firm of Ernst & Young serves as the Company’s independent auditor.

Where is BioMimetic headquartered?
BioMimetic’s principal corporate offices are located at:
389 Nichol Mill Lane
Franklin, TN 37067